Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bristol-Myers Squibb (DE:BRM)
XETRA:BRM
Holding DE:BRM?
Track your performance easily
See the Price Targets and Ratings of:
BRM Analyst Ratings
Hold
3 Buy
10 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BRM Stock 12 Month Forecast
Average Price Target
€50.06
▼(-1.48% Downside)
| Highest Price Target€59.33 | Average Price Target€50.06 | Lowest Price Target€33.37 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Leerink Partners
Reiterated
11/04/24
Truist Financial
Reiterated
11/01/24
Barclays
Reiterated
11/01/24
Morgan Stanley
Reiterated
11/01/24
TD Cowen
Reiterated
11/01/24
Bank of America Securities
Assigned
11/01/24
Jefferies
Assigned
10/31/24
Wells Fargo
Reiterated
10/31/24
BMO Capital
Assigned
10/31/24
J.P. Morgan
Reiterated
10/31/24
Citi
€69.53→€50.99
Hold
0.35%
Upside
Downgraded
10/25/24
Bristol Myers downgraded to Neutral from Buy at CitiBristol Myers downgraded to Neutral from Buy at Citi
Bernstein
€51.91
Hold
2.17%
Upside
Initiated
10/17/24
Bristol Myers initiated with a Market Perform at BernsteinBristol Myers initiated with a Market Perform at Bernstein
UBS
€46.35→€50.06
Hold
-1.48%
Downside
Reiterated
10/09/24
Bristol Myers price target raised to $54 from $50 at UBSBristol Myers price target raised to $54 from $50 at UBS
Goldman Sachs
€52.84
Buy
4.00%
Upside
Reiterated
09/26/24
Bristol-Myers Squibb's Cobenfy Launch Spurs 'Buy' Rating Amid Favorable Market Dynamics
Best Analysts Covering Bristol-Myers Squibb
Which Analyst Should I Follow If I Want to Buy DE:BRM and Sell After:
1 Month
xxx
Success Rate
6/12 ratings generated profit
Average Return
-1.07%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -1.07% per trade.
3 Months
xxx
Success Rate
12/20 ratings generated profit
Average Return
+1.48%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +1.48% per trade.
1 Year
Success Rate
14/20 ratings generated profit
Average Return
+6.62%
reiterated a sell rating 10 days ago
Copying Terence Flynn's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +6.62% per trade.
2 Years
xxx
Success Rate
17/26 ratings generated profit
Average Return
+6.57%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 65.38% of your transactions generating a profit, with an average return of +6.57% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BRM Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
1
0
0
0
0
Buy
4
3
7
6
7
Hold
18
15
21
21
20
Sell
4
6
9
7
7
Strong Sell
0
0
0
0
0
total
27
24
37
34
34
Each month's total comprises the sum of three months' worth of ratings.
BRM Financial Forecast
BRM Stock Forecast FAQ
What is DE:BRM’s average 12-month price target, according to analysts?
Based on analyst ratings, Bristol-Myers Squibb’s 12-month average price target is €50.06.
What is DE:BRM’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:BRM, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Bristol-Myers Squibb a Buy, Sell or Hold?
Bristol-Myers Squibb has a consensus rating of Hold, which is based on 3 buy ratings, 10 hold ratings and 2 sell ratings.
What is Bristol-Myers Squibb’s share price target?
The average share price target for Bristol-Myers Squibb is €50.06. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €59.33 ,and the lowest forecast is €33.37. The average share price target represents -1.48% Decrease from the current price of €50.81.
The highest analyst share price target is €59.33 ,and the lowest forecast is €33.37. The average share price target represents -1.48% Decrease from the current price of €50.81.
What do analysts say about Bristol-Myers Squibb?
Bristol-Myers Squibb’s analyst rating consensus is a Hold. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of Bristol-Myers Squibb?
To buy shares of DE:BRM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.